Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Combining glucagon-like peptide 1 analogues with sodium-glucose cotransporter 2 inhibitors to treat patients with type 1 diabetes, BMI > 25 kg/m2, and chronic kidney disease – A randomised, controlled pilot study
PaperCitations, authors & open-access status
Combining glucagon-like peptide 1 analogues with sodium-glucose cotransporter 2 inhibitors to treat patients with type 1 diabetes, BMI > 25 kg/m2, and chronic kidney disease – A randomised, controlled pilot study is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 2 citations, 2025 year and hybrid oa status.
2
Citations
2025
Year
hybrid
OA Status